Review and answer 23 questions about the article and the article supplement. Be very detail with each answers

profileMichelle_Michy
20200428202751answer_these_questions1.docx

Answer each question with detail answers regarding the article and article supplement

1. The overall objective(s) of the guideline is (are) specifically described.

2. The health question(s) covered by the guideline is (are) specifically described.

3. The population (patients, public, etc.) to whom the guideline is meant to apply

is specifically described.

4. The guideline development group includes individuals from all relevant

professional groups.

5. The views and preferences of the target population (patients, public, etc.) have

been sought.

6. The target users of the guideline are clearly defined.

7. Systematic methods were used to search for evidence.

8. The criteria for selecting the evidence are clearly described

9. The strengths and limitations of the body of evidence are clearly described.

10. The methods for formulating the recommendations are clearly described

11. The health benefits, side effects, and risks have been considered in

formulating the recommendations.

12. There is an explicit link between the recommendations and the supporting

evidence.

13. The guideline has been externally reviewed by experts prior to its publication.

14. A procedure for updating the guideline is provided.

15. The recommendations are specific and unambiguous

16. The different options for management of the condition or health issue are

clearly presented.

17. Key recommendations are easily identifiable.

18. The guideline describes facilitators and barriers to its application.

19. The guideline provides advice and/or tools on how the recommendations can

be put into practice.

20. The potential resource implications of applying the recommendations have

been considered.

21. The guideline presents monitoring and/or auditing criteria.

22. The views of the funding body have not influenced the content of the guideline.

23. Competing interests of guideline development group members have been recorded and addressed.